(Q35733803)

10 August 2017

1 reference

title

Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics (English)

1 reference

10 August 2017

1

Charles N Serhan

1 reference

10 August 2017

Nan Chiang

2

1 reference

10 August 2017

publication date

1 February 2004

1 reference

Rheumatic Diseases Clinics of North America

10 August 2017

published in

1 reference

10 August 2017

volume

30

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

69-95

1 reference

Points of control in inflammation

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Polyisoprenyl phosphates in intracellular signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Regulation of leukocyte-endothelial interactions by glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxin biosynthesis and its impact in inflammatory and vascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Aspirin as prophylaxis against colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipid mediator class switching during acute inflammation: signals in resolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Thiazolidinediones as a novel class of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxin A4Analogues Inhibit Leukocyte Recruitment toPorphyromonas gingivalis: A Role for Cyclooxygenase-2 and Lipoxins in Periodontal Disease†

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxins are potential endogenous antiinflammatory mediators in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

A novel rat lipoxin A4 receptor that is conserved in structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Formyl-peptide receptors revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

The scent of a phagocyte: Advances on leukotriene b(4) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900117-0

7 January 2021

10.1016/S0889-857X(03)00117-0

Identifiers

DOI

1 reference

10 August 2017

1 reference